Green light for generic rival to Nexium
Indian company Ranbaxy has been given clearance to launch a generic rival to AstraZeneca’s gastrointestinal drug Nexium in the UK
In a judgment today, Mr Justice Kitchin found that Ranbaxy’s product, which it plans to import from India, does not infringe AstraZeneca’s European patent for magnesium esomeprazole.
The Indian company had sought a declaration of non-infringement and invalidity...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.